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Abstract
Ghrelin is a stomach-derived hormone that regulates food intake and neuroendocrine function by acting on its receptor,
GHSR (Growth Hormone Secretagogue Receptor). Recent evidence indicates that a key function of ghrelin is to signal stress to
the brain. It has been suggested that one of the potential stress-related ghrelin targets is the CRF (Corticotropin-Releasing
Factor)-producing neurons of the hypothalamic paraventricular nucleus, which secrete the CRF neuropeptide into the
median eminence and activate the hypothalamic-pituitary-adrenal axis. However, the neural circuits that mediate the
ghrelin-induced activation of this neuroendocrine axis are mostly uncharacterized. In the current study, we characterized in
vivo the mechanism by which ghrelin activates the hypophysiotropic CRF neurons in mice. We found that peripheral or
intra-cerebro-ventricular administration of ghrelin strongly activates c-fos – a marker of cellular activation – in CRF-
producing neurons. Also, ghrelin activates CRF gene expression in the paraventricular nucleus of the hypothalamus and the
hypothalamic-pituitary-adrenal axis at peripheral level. Ghrelin administration directly into the paraventricular nucleus of
the hypothalamus also induces c-fos within the CRF-producing neurons and the hypothalamic-pituitary-adrenal axis,
without any significant effect on the food intake. Interestingly, dual-label immunohistochemical analysis and ghrelin
binding studies failed to show GHSR expression in CRF neurons. Thus, we conclude that ghrelin activates hypophysiotropic
CRF neurons, albeit indirectly.
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Introduction
Ghrelin is a peptide hormone derived from the gastro-intestinal
tract [1]. Ghrelin acts on the central nervous system to regulate
different actions, including the control of growth hormone
secretion, food intake/energy expenditure regulation and glucose
homeostasis regulation [1–4]. Recent evidence indicates that
ghrelin also participates in physiological responses to various forms
of stress [5]. We and others have found that plasma ghrelin rises in
response to stress induced by acute or chronic caloric restriction
[6–10]. Ghrelin also rises in response to various forms of acute or
chronic psychological stress. For instance, elevations in gastric
ghrelin gene expression and plasma ghrelin have been also
observed in rodents’ response to acute stress, including tail pinch
stress and water avoidance stress [11,12]. Rises in plasma ghrelin
levels were shown in rodents stressed by chronic social defeat or
exposure to a continuously flooded cage [13–15]. Importantly,
human beings subjected acutely to psychosocial stress also display
increased plasma ghrelin [16]. Mice with genetic deletion of
GHSR were unable to respond as wild-type mice to stress-induced
alterations of mood, feeding and metabolism suggesting that
elevated plasma ghrelin participates in stress-associated responses
[5,13,15]. However, the circuit by which ghrelin engages these
responses are not yet elucidated.
One potential mechanism might include activation of the
hypothalamic-pituitary-adrenal (HPA) neuroendocrine axis,
which is one of the targets of ghrelin’s central actions. In
response to stress, activation of corticotropin-releasing factor
(CRF)-producing neurons of the paraventricular nucleus of the
hypothalamus (PVN) leads to secretion of CRF into the median
eminence, and a subsequent stimulation of adrenocorticotropic
hormone (ACTH) secretion from the pituitary gland [17]. In
turn, ACTH acts on the adrenal cortex to release glucocorticoids
that have a variety of important effects including increases in
glycemia and body weight [18]. Recently, a role of ghrelin as an
activator of the HPA axis has been documented [19,20]. Ghrelin
appears to activate the HPA axis by acting at the hypothalamic
level. For instance, ghrelin releases CRF from hypothalamic
explants in vitro [19,20]. Also, centrally administrated ghrelin
stimulates CRF mRNA expression in the hypothalamus and
increases ACTH and glucocorticoid plasma levels in rodents
[19,21]. Importantly, ghrelin administration strongly stimulates
ACTH and cortisol release in healthy lean humans [22,23]. It is
yet unclear, however, whether ghrelin’s effects on the HPA axis
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indirect pathways.
In the present study, we systematically examined the responses of CRF-
producing neurons and of the HPA axis in mice after peripheral and
central ghrelin treatment. To further assess the functional consequence of
ghrelin actions on the PVN, we directly administered the hormone into
this nucleus. Finally, we assessed if CRF-producing neurons express
ghrelin receptor. Our results indicate that peripheral, central and intra-
PVN ghrelin administration strongly activate hypophysiotropic CRF
neurons and, as a consequence, the HPA axis. This action, however,
seems to be indirect since CRF neurons fail to express GHSR.
Materials and Methods
Animals
Adult (2–3 months old) C57BL6/J mice were from Jackson
Laboratory or generated in the animal facility of the IMBICE.
Male mice were housed in a 12-h light/dark cycle with regular
chow and water available ad lib. All experimentation received
approval from the Institutional Animal Care and Use Committees
located in The University of Texas Southwestern Medical Center
(approval ID 1090-06-06-1) and Multidisciplinary Institute of Cell
Biology (approval ID 10-0112).
Treatments and stereotaxic surgeries
In the first experiment, mice were subcutaneously injected with
saline or acyl-ghrelin (2 mg/g body weight, Global Peptide, cat.
#C-et-004), as previously done [9]. For central infusion of ghrelin,
two different variants of stereotaxic surgeries were performed. For
one experiment, mice were stereotaxically implanted with a single
indwelling sterile guide cannula (4 mm long, 22 gauge, Plastics
One, Inc. Roanoke, VA) into the lateral ventricle (intra-cerebro-
ventricular, ICV). The placement coordinates for the lateral
ventricle were: AP:20.34 mm; L:+1 mm and V:22.3 mm. A 28-
gauge obturator was inserted into each cannula. After surgery,
animals were individually housed and allowed to recover for at
least 5 days. Mice were made accustomed to handling by removal
of the dummy cannula and connection to an empty cannula
connector daily for at least 4 days prior to experimentation, to
reduce stress. Correct placement of the cannula was confirmed by
histological observation at the end of the experiment. On the
morning of the experimental day, animals were ICV injected with
4 mL of vehicle (artificial cerebrospinal fluid, aCSF) with or
without acyl-ghrelin (2 mg/mouse). We have successfully studied
the actions of ghrelin on food intake using this protocol, previously
[24]. All ICV injections were made over 2 min through a 30 gauge
needle that extend 0.5 mm below the guide cannula and that was
connected by polyethylene tubing to a 5 mL Hamilton syringe.
The needle was left in place for 2 min, following the injection, to
prevent back flow of the injected solution. Between injections and
sacrifices, mice were exposed to a pre-weighed amount of rodent’s
food, except when indicated. In another experiment, mice were
stereotaxically implanted with a double indwelling sterile guide
cannula (10 mm long, 26 gauge, Plastics One, Inc. Roanoke, VA).
The placement coordinates were: AP:20.82 mm; L:60.5 mm and
V:22.0 mm. After surgery, mice were manipulated as described
above. On the morning of the experimental day, animals were
injected with a 30 gauge needle that was extended to 2.8 mm
below the guide cannula; thus, allowing injections to be made
500 mm dorsal to the PVN. We administered 0.5 mL of sterile
saline with or without acyl-ghrelin (0.1 mg) on each side of the
PVN. Injections were made with a 2 mL Hamilton syringe, over
2 min. PVN injections were verified post-mortem by histological
visualization of the injection cannula tracts. Finally, one group of
mice was stereotaxically injected with colchicine (16 mgi n4mL
per mouse, Sigma-Aldrich) into the lateral ventricle using the
above described coordinates. After surgery, animals were allowed
to recover for 2 days and used as described below.
Assessment of c-fos and CRF colocalization by
immunohistochemistry (IHC)
Two hours after vehicle or ghrelin treatment, anesthetized mice
were perfused with formalin as previously described [10]. This
time point was chosen based on previous evidence showing that
increases of c-fos gene expression occur after CRF gene expression
and that the presence of nuclear c-fos protein requires not only
gene expression, but also protein biosynthesis and mobilization
from cytoplasm to the cell nucleus [25,26]. Brains were removed,
post-fixed, immersed in 20% sucrose, and cut coronally at 20 mm
into three equal series on a sliding cryostat. Double c-fos/CRF
staining was performed as described [9]. Briefly, sections were
pretreated with 1% H2O2, treated with blocking solution (3%
normal donkey serum and 0.25% TritonX in PBS), and incubated
with anti-c-fos antibody (Calbiochem/Oncogene, Temecula, CA,
cat# PC38, 1:15,000) for two days at 4uC. Then, sections were
treated with biotinylated donkey anti-rabbit antibody (Jackson
ImmunoResearch Laboratories, West Grove, PA, 1:1,000) for 1 h,
and with Vectastain Elite ABC kit (Vector Laboratories,
Burlingame, CA) for 1 h, according to manufacturer’s protocols.
Then, visible signal was developed with 3-39-diaminobenzidine
(DAB)/Nickel solution, giving a black/purple precipitate. Con-
secutively, sections were washed and incubated overnight with
anti-CRF antibody (1:2,000). This antibody recognizes mature
CRF(1–41) and full pre-proCRF prohormone [27]. The next day,
sections were sequentially incubated with biotinylated donkey anti-
rabbit antibody and Vectastain Elite ABC kit as detailed above.
Finally, visible signal was developed by incubation with DAB
solution, giving a brown precipitate. Sections were sequentially
mounted on glass slides, and cover slipped with mounting media.
Results were visualized using bright-field light sources. Bright-field
images were acquired with a Nikon Eclipse 50i (Nikon, Japan) and
a DS-Ri1 Nikon digital camera (Nikon, Japan). An image editing
software program, Adobe Photoshop CS2 (San Jose, CA), was
used to adjust contrast and brightness. CRF immunostaining was
confined to the perikarya and dendrites, thus allowing visualiza-
tion of the nucleus with or without black/purple label for c-fos.
The relationship was expressed as a percentage, which represents
CRF immunoreactive (IR) neurons positive for c-fos compared to
the total number of CRF-IR neurons observed. The data were
corrected for double counting, according to the method of
Abercrombie [28] where the ratio of the actual number of
neurons to the observed number is represented by T/T+h where
T=section thickness, and h=the mean diameter of the neuron
along the axis perpendicular to the plane of section. The mean
diameter of the neurons was determined with the software
program Image J. For the analysis, the mouse PVN was
subdivided into five parts, which were named: compact,
periventricular, anterior, medial and posterior, as previously
suggested [29]. The percentage of CRF neurons containing
labeled nuclei was determined in the compact part of the PVN,
located between 20.70 mm and 20.94 mm from bregma, where
CRF neurons are enriched and most hypophysiotropic PVN
neurons are located (see below) [30]. Quantitative analysis was
performed in 3–4 animals per condition.
Assessment of responsiveness of the HPA axis to ghrelin
ICV ghrelin- or vehicle-treated animals were sacrificed by
decapitation at 0, 15, 30, 60 or 120 min after treatment (n=526
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remaining at the end of each time point, and food intake was
calculated by subtracting these values from one another. Blood
samples were immediately collected and processed for corticoste-
rone analysis, which was accomplished using an ELISA kit
according to the procedures and reagents provided (Assay
Designs). Brains were extracted, placed in cold diethylpyrocarbo-
nate-phosphate buffered saline (PBS), and sectioned into 1 mm
coronal slices by use of a mouse brain matrix. Small ‘‘punches’’ of
tissue corresponding to the location of PVN (identified by
comparing the coronal slices to a mouse brain atlas) were excised
using a 15 g needle. Cannula position was verified at the end of
the experiment by visualization of the injection cannula tracts.
PVN punches were collected in TRIzol Reagent (Invitrogen Inc,
Carlsbad, CA).Total RNA was isolated from PVN punches using
RNA STAT-60 (Tel-Test Inc.) and quantified by absorbance at
260 nm. The total RNA was treated with RNase-free DNase
(Roche) and reverse-transcribed into cDNA with random hexamer
primers and SuperScript II reagents (Invitrogen). Quantitative
PCR was performed using an Applied Biosystems 7900HT
sequence detection system and SYBR-green chemistry (Applied
Biosystems, Foster City, CA). The CRF mRNA levels are
expressed relative to the housekeeping gene Cyclophilin A,
calculated by the comparative threshold cycle (Ct) method, and
then the data is presented as a percentage of levels observed in
PVN punches. Primers sequences for CRF were Sense:
59-TCTGGATCTCACCTTCCACCT-39, Antisense: 59-CCAT-
CAGTTTCCTGTTGCTGT-39 [GenBank Accession No. NM_
205769], product size 95. Primers sequences for Cyclophilin A
Sense: 59-TGGTCTTTGGGAAGGTGAAAG-39, Antisense:
59-TGTCCACAGTCGGAAATGGT-39 [GenBank Accession
No. NM_008907] product size 109. All reactions were performed
in triplicate in sealed fast optical 96-well reaction plates (Applied
Biosystems). Standard curves for CRF and Cyclophilin A
transcript levels were generated using hypothalamic cDNA of
mouse with ABI 7500 Fast System SDS Software version 1.3.1
(Applied Biosystems). Averaged levels of CRF normalized to
Cyclophilin A in each experimental group were compared with
similar values obtained from vehicle-treated mice to determine
relative expression levels.
Visualization of ghrelin binding sites in brain sections
The procedure for ghrelin binding was adapted from a
previously-described protocol [31]. Initially, brain sections were
pretreated with 0.5% H2O2 and treated with blocking solution
(3% normal donkey serum and 0.25% TritonX in PBS). Then,
brain sections were incubated with acyl-ghrelin (10 mg/mL,
Global Peptide, cat #C-et-004) in PBS for 1 hour at 37uC. Next,
coronal sections were brought to room temperature, dipped in
0.5% formaldehyde for 30 minutes, and then rinsed six times in
PBS buffer. Then, brain sections were incubated with goat anti-
ghrelin antibody (Santa Cruz, cat# sc-10368, 20 mg/mL)
overnight at room temperature. The next day, sections were
washed and treated with biotinylated donkey anti-goat antibody
(Jackson ImmunoResearch Laboratories, West Grove, PA,
1:1,000) for 1 h, and with Vectastain Elite ABC kit (Vector
Laboratories, Burlingame, CA) for 1 h, according to manufactur-
er’s protocols. Finally, visible signal was developed with DAB/
Nickel solution, giving a black/purple precipitate. To determine
the specificity of the reaction, coronal sections were incubated with
decreasing concentrations of ghrelin (0–1 mg/mL) and the
intensity of signal was subsequently measured. Negative controls
were also performed using the same procedure but omitting the
primary antibody. Sections were sequentially mounted on glass
slides, and cover slipped with mounting media. Results were
visualized using bright-field light sources. Bright-field images were
acquired with a Nikon Eclipse 50i (Nikon, Japan) and a DS-Ri1
Nikon digital camera (Nikon, Japan).
Assesment of GHSR mRNA levels in the PVN and ARC
Anesthetized mice were sacrificed by decapitation. PVN and
ARC punches from these mice were used to isolate total RNA,
which was then submitted to reverse-transcription into cDNA and
quantitative PCR, as described above. Primers mGHSR-QF1, 59-
ACCGTGATGGTATGGGTGTCG-39 and mGHSR-QR1, 59-
CACAGTGAGGCAGAAGACCG-39 amplify a product within
Exon 2 of the GHSR gene. These primers were previously
extensively validated using template titration and dissociation
curves [15].
Assessment of dual GHSR mRNA expression and CRF
immunoreactivity in the PVN
This was performed by using in situ hybridization histochemistry
(ISHH) for GHSR and IHC for CRF. Two days after colchicine
treatment, animals were perfused and brain slice sections obtained
as described above. Free-floating sections of mouse brains were
processed sequentially by ISHH and then IHC using a protocol
reported previously [10]. Series of three different mouse brains
were processed for GHSR-CRF co-expression. Briefly, brain
sections were thoroughly washed and incubated with a
35S-labeled
GHSR mouse cRNA riboprobe [10
6 cpm/mL in a hybridization
solution previously reported], which was generated as previously
explained in detail [10]. Next, sections were incubated at 57uC
overnight in hybridization solution. Subsequently, sections were
rinsed, treated with RNase solution A (Roche Molecular
Biochemicals, Indianapolis, IN) and thoroughly washed with
stringent buffers. IHC was begun on the same ISHH-processed
sections. Sections were treated as explained above and incubated
overnight at room temperature in polyclonal anti-CRF antiserum
made in goat (Santa Cruz. no. A-6455, lot 71B1, 1:2,000 in PBT-
azide). Next day, section were developed with DAB as described
above and mounted onto SuperFrost Plus slides (Fisher Scientific,
Pittsburgh, PA). ISHH patterns were visualized first on autora-
diographic film and then by observing slides dipped in
photographic emulsion for direct, cellular visualization. Of note,
one series of coronal sections from each mouse was used for ISHH
plus thionin-counterstaining, without any further IHC staining.
Brain sections were viewed with both a Zeiss Axioskop and a Zeiss
Stemi 2000-C dissecting microscope using both brightfield and
darkfield optics. Photomicrographs were produced with a Zeiss
digital camera. Criteria used to determine whether a CRF-IR cell
co-expressed GHSR mRNA included both 1) bright field
visualization of silver granules overlying the DAB-stained cell at
56 the background density of silver granule deposition, and 2)
conformation of the overlying silver granules to the shape of the
DAB-stained cell. Cell counts were performed on every third
section of each mouse brain, as done in the past [10]. Estimates of
cell counts were performed using a 106 objective. An image
editing software program, Adobe PhotoShop 7.0 (San Jose, CA),
was used to adjust sharpness, contrast and brightness in the
photomicrographs.
Statistical analyses
Data is expressed as the mean6SEM. The t-test for each time
point was performed when assessing ghrelin-induced changes on
CRF gene expression and plasma corticosterone. One-way
ANOVA was used to compare percentage CRF-IR neurons
Ghrelin-Induced Activation of CRF Neurons
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three experimental groups per experiment (vehicle, ghrelin/food
and ghrelin/no food). Also, one-way ANOVA was performed
when comparing CRF gene expression and plasma corticosterone
data of ghrelin microinjection into the PVN. Significant
differences were considered when P,0.05.
Results
Peripheral ghrelin administration activates CRF neurons
of the PVN and the HPA
To ascertain whether ghrelin modulates CRF neurons and the
HPA axis, we injected ad lib-fed C57BL6/J mice with ghrelin
(2 mg/g BW, sc) or saline. In our experimental conditions, we
detected 29626276 CRF-IR neurons within the combined mouse
PVNs, with an average cytoplasmic diameter of 10.560.6 mm.
CRF-IR neurons were located throughout the whole rostral-to-
caudal axis of the PVN, although they were strongly enriched
within the compact part in the middle level of the nucleus. Within
this compact part, 67.461.8% of all CRF-IR PVN neurons were
concentrated. We found that ghrelin, 2 h after administration,
induces a profound increase of c-fos immunoreactivity within both
the arcuate (ARC, Figure 1A–B) and the PVN (Figure 1C–D).
The total number of CRF-IR cells in the PVN (27146217
neurons) and their average diameter (10.360.5 mm) were not
significantly affected by acute subcutaneous ghrelin administra-
tion. In the PVN, ghrelin-treated mice had a significant increase in
the percentage of CRF-IR neurons positive for c-fos as compared
to the levels found in vehicle-treated animals. Double positive cells
were particularly observed in compact part of the PVN in ghrelin-
treated mice (Figure 1E–F). In the compact part, the quantitative
analysis indicated that 12.166.6% of the CRF-IR cells were
positive for c-fos in control animals. Conversely, 72.965.4% of
CRF-IR neurons were positive for c-fos in ghrelin-treated animals
(p,0.01 vs. vehicle-treated group, n=3 per group). Importantly,
ghrelin-treated mice with no access to food had 64.166.3% of
CRF-IR neurons positive for c-fos in the compact part of the PVN
(p,0.01 vs. vehicle-treated group, n=3 per group), suggesting
that the ghrelin-induced activation CRF neurons of the PVN is
independent of the ghrelin-induced increase of food intake. The
responsiveness of the HPA axis was quantified by measurements of
plasma glucocorticoids. Peripheral administration of ghrelin
significantly increased plasma corticosterone levels one hour after
treatment to 10.362.4 ng/mL, as compared to vehicle-treated
mice that had 2.160.4 ng/mL (p,0.01, n=7 per group). Plasma
corticosterone levels also increased, one hour after treatment, in
ghrelin-treated mice that had no access to food (11.461.9 ng/mL,
n=4).
Central ghrelin administration activates CRF neurons of
the PVN and the HPA axis
In order to rule out any potential contribution of peripheral
actions of ghrelin to these observations, we tested the response of
CRF PVN neurons and the HPA axis to central administration of
the hormone. In this experiment, we injected ad lib-fed mice with
ghrelin (2 mgi n4mL per mouse, ICV) or vehicle. Central ghrelin
administration increased c-fos immunoreactivity in the ARC
(Figure 2A–B). In the compact part of the PVN, we observed a
significant increase of the percentage of CRF-IR neurons positive
for c-fos, 2 h after treatment (Figure 2C–D). In this part,
10.461.6% of the CRF-IR cells were positive for c-fos in vehicle-
treated animals, while 72.2611.1% of CRF-IR neurons were
positive for c-fos in ghrelin-treated mice (p,0.01 vs. vehicle-
treated group, n=3 per group). The total number or cytoplasmic
diameter of CRF-IR cells in the PVN was not affected by ICV
ghrelin (data not shown). The percentage of CRF-IR neurons
positive for c-fos in the PVN also increased in ICV ghrelin-treated
mice that had no access to food (87.664.6%, p,0.01 vs. vehicle-
treated group, n=3). Thus, the ghrelin-induced activation of CRF
neurons of the PVN seems to be independent of access to ghrelin-
induced increase of food intake, as observed with peripheral
administration of ghrelin.
To further study the role of ghrelin on CRF neurons and more
specifically determine the HPA axis response, we sacrificed
animals at multiple time points following central ghrelin
administration and analyzed changes in CRF gene expression
and corticosterone levels. Ghrelin induced a significant increase of
CRF gene expression in the PVN at 15 and 30 min post treatment
Figure 1. Ghrelin administration activates CRF neurons of the
PVN. Panels A to D show representative photomicrographs of brains
sections subjected to double immunohistochemistry using anti-CRF
(brown staining) and anti-c-fos (purple-black staining) antiserum. Upper
panels show the ARC and bottom panels show the PVN. Images of
panel A and C are from a vehicle-treated mouse and images of panel B
and D from a ghrelin-treated mouse. Inserts in PVN images show high
magnification of areas marked in low magnification images. Arrows
point to dual-labeled cells. Scale bars, 100 mm (low magnification),
10 mm (high magnification). Panels E and F show schematic drawings of
middle level of the PVN of a vehicle- and ghrelin-treated mouse,
respectively. Filled circles represent CRF-IR neurons positive for c-fos,
and open circles indicate single-labeled CRF-IR cell bodies. Gray letters
indicate the PVN subdivisions: P: periventricular; M: medial; C: compact.
doi:10.1371/journal.pone.0031462.g001
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levels in the control to 2.1560.24 relative CRF mRNA levels, at
15 min post treatment (P,0.05, n=5 per group). Also, ghrelin
induced a significant increase in plasma corticosterone levels at 15,
30 and 60 min post treatment. The maximum response was
observed at 60 min post treatment (Figure 3B), when plasma
corticosterone was 8.761.5 ng/mL in ghrelin-treated mice and
1.760.4 ng/mL in saline-treated mice (P,0.05, n=5 per group).
Ghrelin microinjection into the PVN activates CRF
neurons and the HPA axis
Ghrelin receptors are expressed in several brain nuclei,
including the PVN [32]. In order to focus our studies on the
PVN, we micro-injected ghrelin directly to this nucleus via an
injector cannula located 500 mm dorsal of each PVN (Figure 4A–
B). For these studies, we injected ad lib-fed mice with ghrelin
(0.1 mg in 0.5 mL per side per mouse) or vehicle. Those mice with
correctly placed cannulas were analyzed as ‘‘hits’’, while those
mice with incorrectly placed cannulas were separately grouped as
‘‘misses’’. Two hours after treatment, ghrelin infusion into the
PVN produced a massive increase in c-fos immunoreactivity
exclusively in this nucleus in the ghrelin-treated ‘‘hits’’ group
(Figure 4D), as compared to the ‘‘saline-treated’’ group
(Figure 4C). The ghrelin-treated ‘‘misses’’ group failed to show
any significant increase of c-fos signaling within the PVN
(Figure 4E). In contrast, no c-fos was observed in the ARC of
ghrelin-injected mice suggesting that ghrelin’s infusion was limited
to the PVN, as intended (Figure 5A–B). Ghrelin infusion into the
PVN increased the percentage of CRF-IR neurons positive for c-
fos to 66.863.0% in the compact part (Figure 5D, n=3 per
group). In contrast, few of the CRF-IR cells were positive for c-fos
in the saline-treated group (Figure 5C, 17.060.5%, p,0.01 vs.
ghrelin-treated group, n=3). Despite this effect on c-fos induction,
ghrelin infusion into the PVN did not induce any significant food
intake in mice as compared to saline-treated mice and ghrelin-
treated ‘‘misses’’. Ghrelin infused into the PVN induced a
significant increase of the relative CRF mRNA levels at 30 min
post treatment in ghrelin-treated ‘‘hits’’ group (2.1360.29) as
compared to vehicle-treated mice (1.3260.10) and ‘‘misses’’
(1.2460.13) (P,0.05, Figure 6A). Also, plasma corticosterone
levels significantly increased in ghrelin-treated ‘‘hits’’ (7.161.5 ng/
mL) at 30 min post treatment as compared to vehicle-treated mice
(1.560.2 ng/mL) and ‘‘misses’’ (2.160.5 ng/mL) (P,0.05,
Figure 6B).
CRF-IR neurons of the PVN do not express GHSR
Finally, we tested the capacity of CRF neurons to respond
directly to ghrelin by assessing the capacity of exogenous ghrelin to
bind to the compact part of the PVN. Internal positive controls for
Figure 2. ICV ghrelin administration activates CRF neurons of
the PVN. Panels show representative photomicrographs of brains
sections subjected to double immunohistochemistry using anti-CRF
(brown staining) and anti-c-fos (purple-black staining) antiserum. Upper
panels show the ARC and bottom panels show the PVN. Images of
panel A and C are from a vehicle-treated mouse and images of panel B
and D from a ghrelin-treated mouse. Inserts in PVN images show high
magnification of areas marked in low magnification images. Arrows
point to dual-labeled cells. Scale bars, 100 mm (low magnification),
10 mm (high magnification).
doi:10.1371/journal.pone.0031462.g002
Figure 3. ICV ghrelin administration activates the HPA axis.
Panel A shows comparative values of RT-qPCR for CRF mRNA in the PVN
micro-dissected punches obtained from vehicle-treated and ghrelin-
treated mice sacrificed at different time points. Data is shown as mRNA
levels of CRF relative to the housekeeping gene Cyclophilin A,
calculated by the comparative threshold cycle (Ct) method. Panel B
shows comparative values of specific ELISA for plasma corticosterone
obtained from vehicle- and ghrelin-treated mice sacrificed at different
time points. Data represent the mean6SEM. *p#0.05. **p#0.01.
***p#0.001.
doi:10.1371/journal.pone.0031462.g003
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(VMH), where GHSR is expressed [32]. As expected, ghrelin
binding was strongly located in cell bodies within the ARC and the
ventrolateral subdivision and the capsule of the VMH (Figure 7A),
as previously described for mouse GHSR expression [32]. The
binding assay showed specificity as no signal was observed when
ghrelin was omitted from the assay (Figure 7B) and the intensity
of signal increased when coronal sections were incubated with
increasing concentrations of ghrelin (0.1 or 1 mg/mL, see
Figure 7C and 7D, respectively). Ghrelin binding was also
observed in the PVN; although positive cells were scarce
(Figure 7C–D). Of note, the ghrelin binding signal in the PVN
was weaker than the signal observed in the ARC region (compare
inserts in A vs. inserts in D). To further assess GHSR gene
expression in the ARC and PVN, we analyzed GHSR mRNA
levels from micro-dissected punches of these brain nuclei. Similar
to the relative GHSR levels determined with the ghrelin binding
assay, the ARC demonstrated the highest GHSR mRNA levels
(CT=24.760.3), whereas the PVN had significantly lower levels of
GHSR mRNA (CT=28.460.4, P,0.01).
To ascertain whether the GHSR-expressing neurons within the
PVN included CRF neurons, we also performed ISHH for GHSR,
as detailed in the past [32]. We confirmed previous results showing
that the ARC contained abundant signal [32], which spanned the
rostral-caudal expanse of the nucleus (Figure 8A). In comparison,
the medial level of the PVN demonstrated few cells positive for
GHSR mRNA expression (Figure 8B). In particular, less than
5% of the cells were positive for GHSR within the compact part of
the mouse PVN, in our experimental conditions. To determine
whether CRF neurons express GHSR, we performed ISHH for
GHSR and IHC for CRF on the same coronal brain sections of
mice. Again, we found abundant GHSR signal in the ARC
(Figure 8C) and minimal GHSR signal in the compact part of the
PVN. However, we were unable to detect cells positive for both
CRF-IR and GHSR mRNA expression in the compact part of the
PVN (Figure 8D).
Discussion
The present study characterizes a role for ghrelin in signaling
stress to the brain and activating the HPA neuroendocrine axis.
Our results indicate that ghrelin is able to activate the CRF
neurons of the PVN, and that this action is sufficient to acutely
increase plasma glucocorticoid levels. However, the lack of
detectable CRF and GHSR co-expressing neurons suggests that
stimulation by ghrelin of the HPA axis occurs via an indirect
mechanism. Interestingly, the ghrelin-induced activation of
hypophysiotropic CRF neurons can occur independently of those
circuitries controlling food intake. Thus, ghrelin’s functions as an
orexogenic signal and as a stress signal likely are dissociated
anatomically.
The activation of the HPA neuroendocrine axis is a potential
mechanism by which ghrelin regulates some physiological
functions. For instance, it has been shown that the fat-
accumulating effects of GHSR signaling are glucocorticoid
dependent [33]. It is likely that the HPA axis also contributes to
the mechanism by which ghrelin affects rewarding aspects of
eating since glucocorticoids intensify motivated behaviors and
increase intake of highly palatable foods [34]. The activation of the
Figure 4. Ghrelin can be microinjected exclusively into the
PVN. Panel A shows a schematic diagram of a coronal section of the
mouse brain with the localization of a correctly implanted cannula
(black). This experimental strategy allowed us to administer vehicle,
containing or not ghrelin, 500 mm above the PVN (blue) via the injector
cannula (gray). Panel B shows a representative photomicrograph of a
coronal brain section subjected to thionin staining of an intra-PVN
injected mouse. Lines label injector cannula tracts, where no thionin
staining is observed. Panels C, D and E show representative
photomicrographs of brain sections, containing the PVN, subjected to
immunohistochemistry using anti-c-fos (purple-black staining) antise-
rum in ‘‘saline-treated’’, ‘‘ghrelin-hits’’ and ‘‘ghrelin-misses’’ groups,
respectively. Scale bars, 100 mm.
doi:10.1371/journal.pone.0031462.g004
Figure 5. Ghrelin microinjection into the PVN activates CRF
neurons. Panels A to B show representative photomicrographs of
brains sections subjected to double immunohistochemistry using anti-
CRF (brown staining) and anti-c-fos (purple-black staining) antiserum.
Upper panels show the ARC and bottom panels show the PVN. Images
of panel A and C are from a vehicle-treated mouse and images of panel
B and D from a ghrelin-treated mouse. Inserts in C and D panels show
high magnification of areas marked in low magnification images.
Arrows to dual-labeled cells. Scale bars, 100 mm (low magnification),
10 mm (high magnification).
doi:10.1371/journal.pone.0031462.g005
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defending against depressive symptoms of chronic stress. In this
regard, we have shown that GHSR-null mice have intensified
social isolation behavior and fail to have a full response of the HPA
axis, as compared to wild type mice, in response to chronic social
defeat stress [15]. Thus, it is likely that the ghrelin-induced
activation of the HPA axis is one of the physiological mechanisms
by which ghrelin helps animals to cope with stress.
It had previously been shown that ghrelin activates the HPA
axis by acting at the hypothalamic level. Activation of GHSR
signaling stimulates CRF mRNA expression in the hypothalamus
when administrated in vivo and releases CRF from hypothalamic
explants in vitro [35]. Moreover, central ghrelin infusion stimulates
Figure 6. Ghrelin microinjection into the PVN activates the HPA
axis. Panel A shows comparative values of RT-qPCR for CRF mRNA in
the PVN micro-dissected punches obtained from intra-PVN ghrelin-
treated, intra-PVN vehicle-treated and misses groups. Data is shown as
mRNA levels of CRF relative to the housekeeping gene Cyclophilin A,
calculated by the comparative threshold cycle (Ct) method. Panel B
shows comparative values of specific ELISA for plasma corticosterone
obtained from intra-PVN ghrelin-treated, intra-PVN vehicle-treated and
misses groups. Data represent the mean6SEM. *p#0.05.
doi:10.1371/journal.pone.0031462.g006
Figure 7. Ghrelin binding to the compact part of the PVN is scarce. This figure shows representative photomicrographs of brains sections
subjected to a ghrelin binding assay (see Material and Methods for details), at low and high magnification (inserts). Purple/Black signal indicates
specific binding of ghrelin. Panel A shows an internal positive control of the assay in which positive ghrelin binding to cells located in the ARC and to
the ventrolateral subdivision of the VMH (vlVMH) is observed, when brain section are incubated with 1 mg/ml of ghrelin. Panel B shows the PVN level
for a negative control, where no exogenous ghrelin was added. Panels C and D show positive ghrelin binding to cells located in the PVN, in brain
section previously incubated with 0.1 or 1 mg/ml of ghrelin, respectively. Inserts in each image show high magnification of areas marked in low
magnification images. Arrows point to labeled cells. Scale bars, 100 mm (low magnification), 10 mm (high magnification).
doi:10.1371/journal.pone.0031462.g007
Figure 8. CRF-IR neurons of the PVN do not express GHSR.
Upper panels show representative ISHH photomicrographs of thionin
counterstained coronal sections of brain mouse. Panels A and B show
photomicrographs of the ARC and PVN, respectively. Black silver
granules, representing the binding of GHSR antisense riboprobes, can
be detected at a higher density in the ARC (A) and with smaller density
in the PVN (B). Bottom panels show representative photomicrographs
of ISHH for GHSR (black silver granules) and IHC for CRF (brown
staining) on coronal brain sections of mice. Panels C and D show
photomicrographs of the ARC and PVN, respectively. Inserts in each
image show high magnification of areas marked in low magnification
images. White arrows point to examples of cells labeled with GHSR
riboprobe. Black arrowhead point to examples of cells labeled with anti-
CRF IHC. Scale bars, 100 mm (low magnification), 20 mm( h i g h
magnification).
doi:10.1371/journal.pone.0031462.g008
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release of ACTH and corticosterone [19,21]. Here, we show that
ghrelin-responsive CRF neurons are concentrated in the compact
part of the PVN, where most of hypophysiotropic neurons are
located [29]. Ghrelin treatment also increases plasma corticoste-
rone levels suggesting that ghrelin-induced activation of the HPA
axis is likely due to increased secretion of CRF into the portal
hypophysiotropic system. Interestingly, local action of ghrelin
within the PVN is sufficient to activate the HPA axis. Future
studies will be required to provide evidence of how and when
ghrelin reaches the PVN. In mice, peripheral acyl-ghrelin crosses
the blood brain barrier at a low rate [36], and its flow into the
central nervous system varies among brain regions and serum
factors [37]. It is currently unclear whether physiological
fluctuations in plasma ghrelin can regulate the HPA axis.
However, our previous finding that corticosterone levels are
higher in chronically stressed wild-type mice as compared to
chronically stressed GHSR-null mice suggests that an intact
ghrelin signaling is required for the full activation of the HPA axis
[15]. Although controversial, some evidence suggests that ghrelin
is also produced in the brain and neuroanatomical studies have
shown ghrelin-IR fibers innervating the PVN [38,39]. Thus, a
potential role of centrally-produced ghrelin as a modulator of
CRF-producing neurons cannot be excluded.
The strong observed effect of ghrelin on the hypophysiotropic
CRF neurons supports the concept that this hormone may play a
role in the physiological regulation of the HPA axis activity. As
indicated, previous studies have shown that plasma ghrelin rises in
response to acute or chronic stress in both rodents and human
beings [6–16]. The mechanisms responsible for the stress-
associated increase in plasma ghrelin have not yet been
determined; however, they likely depend on the sympathetic
nervous system and/or release of catecholamines [40,41]. Elevated
plasma ghrelin could participate in the acute or chronic activation
of the HPA axis in conditions such as upon fasting or caloric
restriction, respectively. For instance, the HPA axis rapidly
readjusts its set point under chronic stress, and a disruption of
the glucocorticoid negative feedback system is observed [42,43].
Thus, it can be hypothesized that the hypothalamic action of
elevated ghrelin could override the negative feedback mediated by
glucocorticoid. In the past, we have shown that leptin affects the
hypophysiotropic TRH neurons sensitivity to the thyroid hor-
mones and, as a consequence, the hypothalamic-pituitary-thyroid
axis changes its set point to negative feedback mechanisms [44,45].
Whether chronically elevated ghrelin levels would affect the
activity and/or set point of the HPA axis will require further study.
The neuronal circuits mediating the ghrelin-induced activation
of the HPA axis have not been thoroughly investigated. A direct
action of ghrelin on the PVN neurons is relevant since it seems to
be independent of the ghrelin-induced food intake. Of note,
previous studies have reported that administration of a similar
amount of ghrelin into the PVN of rats increases food intake [46–
50]. The reason for this discrepancy with our data is unclear;
although species differences might contribute to the difference. In
fact, mouse and rat PVN have neuroanatomical differences [29]
and differential GHSR expression between these species exists in
the PVN [32]. The coronal level of the PVN where ghrelin acts
could be another potential reason of the difference. In our
experiments ghrelin was administrated specifically on the compact
part of the PVN (Figure 5A), where most of hypophysiotropic CRF
neurons are located [29]. Unfortunately, the above mentioned
articles do not include photomicrographs or depictions of the
injectors’ tracts to establish this type of analysis. Also, Olszewski et
al. showed an increase in c-fos-IR in the ARC in the intra-PVN
injected animals, in contrast to our results, suggesting that a
different neural circuit may be recruited in rats [46].
Here, we show that ghrelin indirectly regulates hypophysiotro-
pic CRF neurons, as they failed to expresses GHSR mRNA or
bind exogenous ghrelin in basal conditions. Thus, a number of
potential indirect mechanisms should be considered. One
possibility is that the ghrelin-induced activation of CRF neurons
occurs indirectly via ghrelin action at a presynaptic level on
neuronal terminals coming from the ARC [39]. The ARC plays a
key role in the regulation of the energy balance [51]. It is known
that GHSR is highly expressed in the Neuropeptide Y (NPY)-
producing neurons of the ARC, and that ghrelin directly activates
these neurons [52–54]. Some evidence suggests that the activation
of NPY neurons is critical for ghrelin-induced increase of food
intake [3,55]. However, if NPY also mediates the ghrelin-induced
activation of the CRF neurons is unknown. Such possibility is
supported by previous reports showing that NPY neurons strongly
innervate the CRF neurons of the PVN [56], CRF neurons
express NPY receptors [57], and CRF neurons are directly
activated NPY [58]. In addition, NPY inhibits inhibitory c-
aminobutyric acid inter-neurons of the PVN and thereby
indirectly could increase the activity of the CRF neurons [39].
Of note, this potential mechanism for the ghrelin-induced
activation of CRF neurons might be presynaptic and independent
of the transcriptional activity in the GHSR-expressing neurons, as
indicated by the finding that local intra-PVN injections of ghrelin
induces activation of CRF neurons without any increase of c-fos in
the ARC (Figure 5). As previously shown, we have confirmed that
some PVN neurons express GHSR [32]. Thus, ghrelin action on
non-CRF-containing PVN neurons that synapse onto CRF-
neurons also might explain the ability of intra-PVN ghrelin
administration to activate the HPA axis. Further studies will be
needed to better establish the pathways mediating ghrelin’s action
on the hypophysiotropic CRF neurons.
These studies will help us better understand how the neuronal
circuits that regulate eating behaviors are coordinated with some
neuroendocrine responses key to maintain body homeostasis. The
ghrelin-induced activation of the HPA axis is likely important
acutely to reestablish the internal homeostasis, and also chronically
to mediate some positive long-term effects of ghrelin on blood
glucose and body weight regulation. It is hoped that these
investigations will contribute for the future development of
therapies to treat stress-associated alterations in energy balance,
such as types of obesity or anorexia nervosa.
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